Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_3
1
33%
Ph not_applicable
1
33%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

completed133%
unknown133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_2

Naldebain for Control of Post-Cesarean Section Pain

NCT05187520
terminatednot_applicable

KOREAN Enhanced RecOvery Strategy for Colorectal Surgery

NCT01874730
completedphase_3

Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery

NCT00136682

Clinical Trials (3)

Showing 3 of 3 trials
NCT05187520Phase 2

Naldebain for Control of Post-Cesarean Section Pain

Unknown
NCT01874730Not Applicable

KOREAN Enhanced RecOvery Strategy for Colorectal Surgery

Terminated
NCT00136682Phase 3

Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3